Psychiatric comorbidities and epilepsy: Is it the old story of the chicken and the egg?

Annals of Neurology

Volumn 72, Issue 2, 2012, Pages 153-155

  Kanner, Andres M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMOXAPINE; CLOMIPRAMINE; CLOZAPINE; CYTOKINE RECEPTOR ANTAGONIST; MAPROTILINE; OLANZAPINE; PILOCARPINE; QUETIAPINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY DISORDER; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; EDITORIAL; EPILEPSY; HOSPITALIZATION; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; SEIZURE; SUICIDE ATTEMPT;

COMORBIDITY; EPILEPSY; HUMANS; MENTAL DISORDERS;

EID: 84865606302     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23679     Document Type: Editorial

References (29)

1. Hesdorffer DC, Ishihara L, Mynepalli L, et al. Epilepsy, Suicidality, and Psychiatric Disorders: A Bidirectional Association. Ann Neurol 2012; 72: 184-191.
2. Hesdorffer DC, Hauser WA, Ludvigsson P, et al. Depression and attempted suicide as risk factors for incident unprovoked seizures and epilepsy. 2006; 59: 35-41.
3. Hesdorffer DC, Ludvigsson P, Olafsson E, et al. ADHD as a risk factor for incident unprovoked seizures and epilepsy in children. Arch Gen Psychiatry 2004; 61: 731-736. (Pubitemid 38890808)
4. Hesdorffer DC, Hauser WA, Annegers JF, Cascino G,. Major depression is a risk factor for seizures in older adults. Ann Neurol 2000; 47: 246-249. (Pubitemid 30078574)
5. Chang YT, Chen PC, Tsai IJ, et al. Bidirectional relation between schizophrenia and epilepsy: a population-based retrospective cohort study. Epilepsia 2011; 52: 2036-2042.
6. Adelow C, Anderson T, Ahlbom A, Tomson T,. Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy. Neurology 2012; 78: 396-401.
7. McConnell H, Duncan D,. Treatment of psychiatric comorbidity in epilepsy. In:, McConnell H, Snyder P, eds. Psychiatric comorbidity in epilepsy. Washington, DC: American Psychiatric Press, 1998: 245-361.
8. Alper KR, Schwartz KA, Kolts RL, Khan A,. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry 2007; 62: 345-354. (Pubitemid 47444278)
9. Dailey JW, Mishra PK, Ko KH, et al. Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. Life Sci 1992; 50: 319-326.
10. Jobe PC,. Affective disorder and epilepsy comorbidity in the genetically epilepsy-prone rat (GEPR). In:, Gilliam F, Kanner AM, Sheline YI, eds. Depression and brain dysfunction. London, UK: Taylor & Francis, 2006: 121-157.
11. Favale E, Rubino V, Mainardi P, et al. The anticonvulsant effect of fluoxetine in humans. Neurology 1995; 45: 1926.
12. Specchio LM, Iudice A, Specchio N, et al. Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol 2004; 27: 133-136. (Pubitemid 38746014)
13. Fromm GH, Rosen JA, Amores CY,. Clinical and experimental investigation of the effect of imipramine on epilepsy. Epilepsia 1971; 12: 282.
14. Fromm GH, Wessel HB, Glass JD, et al. Imipramine in absence and myoclonic- astatic seizures. Neurology 1978; 28: 953.
15. Clinckers R, Smolders I, Meurs A, et al. Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D2 and 5-HT1A receptors. J Neurochem 2004; 89: 834-843. (Pubitemid 38684731)
16. Jobe PC, Mishra PK, Browning RA, et al. Noradrenergic abnormalities in the genetically epilepsy-prone rat. Brain Res Bull 1994; 35: 493-504. (Pubitemid 24342101)
17. Hashimoto K, Sawa A, Iyo M,. Increased levels of glutamate in brains of patients with mood disorders. Biol Psychiatry 2007; 25: 1310-1316. (Pubitemid 350060893)
18. Rajkowska G, O'Dwyer G, Teleki Z, et al. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 2007; 32: 471-482. (Pubitemid 46106953)
19. Kumar G, Couper A, O'Brien TJ, et al. The acceleration of amygdala kindling epileptogenesis by chronic low-dose corticosterone involves both mineralocorticoid and glucocorticoid receptors. Psychoneuroendocrinology 2007; 32: 834-842. (Pubitemid 47187577)
20. Maes M,. Major depression and activation of the inflammatory response system. Adv Exp Med Biol 1999; 461: 25-45.
21. Vezzani A, Conti M, De Luigi A, et al. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 1999; 19: 5054-5065. (Pubitemid 29270140)
22. Mazarati AM, Siddarth P, Baldwin RA, et al. Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine. Brain 2008; 131: 2071-2083.
23. Meldrum BS, Anlezark GM, Adam HK, et al. Anticonvulsant and proconvulsant properties of viloxazine hydrochloride: pharmacological and pharmacokinetic studies in rodents and the epileptic baboon. Psychopharmacology (Berl) 1982; 76: 212-217. (Pubitemid 12129393)
24. Piette Y, Delaunois AL, De Shaepdryver AF, et al. Imipramine and electroshock threshold. Arch Int Pharmacodyn Ther 1963; 144: 293-297.
25. Polc P, Schneeberger J, Haefely W,. Effects of several centrally active drugs on the sleep wakefulness cycle of cats. Neuropharmacology 1979; 18: 259-267. (Pubitemid 9143911)
26. Yanagita T, Wakasa Y, Kiyohara H,. Drug dependence potential of viloxazine hydrochloride tested in rhesus monkeys. Pharmacol Biochem Behav 1980; 12: 155-161. (Pubitemid 10103032)
27. Sanacora G, Mason GF, Rothman DL, Krystal JH,. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 2002; 159: 663-665. (Pubitemid 34274953)
28. Hu S, Sheng WS, Ehrlich LC, et al. Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 2000; 7: 153-159. (Pubitemid 30204821)
29. Magnusson A, Stordal E, Brodtkorb E, Steinlein O,. Schizophrenia, psychotic illness and other psychiatric symptoms in families with autosomal dominant nocturnal frontal lobe epilepsy caused by different mutations. Psychiatr Genet 2003; 13: 91-95. (Pubitemid 36724537)